These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23595052)

  • 21. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y; Shirai M; Asada K; Miwa S; Karayama M; Nakamura Y; Inui N; Shirai T; Hayakawa H; Baba S; Suda T
    Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas.
    Jee BC; Suh CS; Kim SH; Moon SY
    Gynecol Obstet Invest; 2008; 66(1):47-52. PubMed ID: 18311079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
    Kazankov K; Rode A; Simonsen K; Villadsen GE; Nicoll A; Møller HJ; Lim L; Angus P; Kronborg I; Arachchi N; Gorelik A; Liew D; Vilstrup H; Frystyk J; Grønbæk H
    Scand J Clin Lab Invest; 2016; 76(1):64-73. PubMed ID: 26549495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma].
    Wan T; Liu JH; Zheng LM; Cai MY; Ding T
    Ai Zheng; 2009 Mar; 28(3):323-7. PubMed ID: 19619451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
    Møller HJ; Grønbaek H; Schiødt FV; Holland-Fischer P; Schilsky M; Munoz S; Hassanein T; Lee WM;
    J Hepatol; 2007 Nov; 47(5):671-6. PubMed ID: 17629586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and clinical significance of cortactin protein in ovarian neoplasms.
    Li A; Zhang L; Zhang X; Jin W; Ren Y
    Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of soluble CD163 in patients with systemic sclerosis.
    Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Ihn H
    Rheumatol Int; 2012 Feb; 32(2):403-7. PubMed ID: 21120485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis.
    Liu Y; Li M; Zhang H; Yin Z; Wang X
    Lupus; 2024 Oct; 33(12):1279-1288. PubMed ID: 39172599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension.
    Jasiewicz M; Kowal K; Kowal-Bielecka O; Knapp M; Skiepko R; Bodzenta-Lukaszyk A; Sobkowicz B; Musial WJ; Kaminski KA
    Cytokine; 2014 Mar; 66(1):40-5. PubMed ID: 24548423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
    Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
    Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
    Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O
    J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H; Mizuno K; Okamoto H
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
    Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.